The Impact of Weight Loss on Weight-related Quality of Life and Health Satisfaction: Results From a Trial Comparing Canagliflozin With Sitagliptin in Triple Therapy Among People With Type 2 Diabetes

References

• . Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol. 2012;8(4):228–236
   Web of Science ®Google Scholar
• . Fontaine KR, Barofsky I. Obesity and health-related quality of life. Obes Rev. 2001;2(3):173–182
   PubMedGoogle Scholar
• . Grandy S, Fox KM, Bazata DD. Association of self-reported weight change and quality of life, and exercise and weight management behaviors among adults with type 2 diabetes mellitus: the SHIELD study. Cardiol Res Pract. 2012;2012:892564
   PubMedGoogle Scholar
• . Fine JT, Colditz GA, Coakley EH, . A prospective study of weight change and health-related quality of life in women. JAMA. 1999;282(22):2136–2142
   PubMed Web of Science ®Google Scholar
• . Kroenke CH, Kubzansky LD, Adler N, Kawachi I. Prospective change in health-related quality of life and subsequent mortality among middle-aged and older women. Am J Public Health. 2008;98(11):2085–2091
   PubMed Web of Science ®Google Scholar
• . Williamson DA, Rejeski J, Lang W, ; Look AHEAD Research Group. Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes. Arch Intern Med. 2009;169(2):163–171
   PubMedGoogle Scholar
• . National Collaborating Centre for Chronic Conditions (UK). Type 2 Diabetes: National Clinical Guideline for Management in Primary and Secondary Care (update). London, UK: Royal College of Physicians (UK); 2008 (NICE Clinical Guidelines, No. 66). http://www.ncbi.nlm.nih.gov/books/NBK53885/. Accessed November 2013
   Google Scholar
• . Snoek FJ. Breaking the barriers to optimal glycaemic control—what physicians need to know from patients' perspectives. Int J Clin Pract Suppl. 2002;July Suppl(129):80–84
   Google Scholar
• . Anderson RM, Funnell MM. Compliance and adherence are dysfunctional concepts in diabetes care. Diabetes Educ. 2000;26(4):597–604
   PubMed Web of Science ®Google Scholar
• . Funnell MM, Anderson RM. Changing office practice and health care systems to facilitate diabetes self-management. Curr Diab Rep. 2003;3(2):127–133
   PubMedGoogle Scholar
• . Inzucchi SE, Bergenstal RM, Buse JB, ; American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364–1379
   PubMed Web of Science ®Google Scholar
• . Povey RC, Clark-Carter D. Diabetes and healthy eating: a systematic review of the literature. Diabetes Educ. 2007;33(6):931–959
   PubMed Web of Science ®Google Scholar
• . Kavookjian J, Elswick BM, Whetsel T. Interventions for being active among individuals with diabetes: a systematic review of the literature. Diabetes Educ. 2007;33(6):962–988
   PubMed Web of Science ®Google Scholar
• . Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ. 2007;33(6):1014–1029
   PubMed Web of Science ®Google Scholar
• . McAndrew L, Schneider SH, Burns E, Leventhal H. Does patient blood glucose monitoring improve diabetes control? A systematic review of the literature. Diabetes Educ. 2007;33(6):991–1011
   PubMed Web of Science ®Google Scholar
• . Volpp KG, John LK, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive-based approaches for weight loss: a randomized trial. JAMA. 2008;300(22):2631–2637
   PubMed Web of Science ®Google Scholar
• . Petry NM, Barry D, Pescatello L, White WB. A low-cost reinforcement procedure improves short-term weight loss outcomes. Am J Med. 2011;124(11):1082–1085
   PubMed Web of Science ®Google Scholar
• . , Look AHEAD Research GroupWing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170(17):1566–1575
   PubMed Web of Science ®Google Scholar
• . Davies M, Speight J. Patient-reported outcomes in trials of incretin-based therapies in patients with type 2 diabetes mellitus. Diabetes Obes Metab. 2012;14(10):882–892
   PubMed Web of Science ®Google Scholar
• . Pi-Sunyer FX. The impact of weight gain on motivation, compliance, and metabolic control in patients with type 2 diabetes mellitus. Postgrad Med. 2009;121(5):94–107
   PubMed Web of Science ®Google Scholar
• . Proper KI, van der Beek AJ, Hildebrandt VH, Twisk JW, van Mechelen W. Short term effect of feedback on fitness and health measurements on self reported appraisal of the stage of change. Br J Sports Med. 2003;37(6):529–534
   PubMed Web of Science ®Google Scholar
• . Bonora E, Calcaterra F, Lombardi S, . Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control. Diabetes Care. 2001;24(12):2023–2029
   PubMed Web of Science ®Google Scholar
• . Guthrie RM. Evolving therapeutic options for type 2 diabetes mellitus: an overview. Postgrad Med. 2012;124(6):82–89
   PubMed Web of Science ®Google Scholar
• . Russell-Jones D, Khan R. Insulin-associated weight gain in diabetes—causes, effects and coping strategies. Diabetes Obes Metab. 2007;9(6):799–812
   PubMed Web of Science ®Google Scholar
• . Leslie WS, Hankey CR, Lean ME. Weight gain as an adverse effect of some commonly prescribed drugs: a systematic review. QJM. 2007;100(7):395–404
   PubMed Web of Science ®Google Scholar
• . Bode B, Stenlöf K, Sullivan D, Fung A, Usiskin K. Efficacy and safety of canagliflozin treatment in older subjects with type 2 diabetes mellitus: a randomized trial. Hosp Pract (1995). 2013;41(2):72–84
   PubMedGoogle Scholar
• . Cefalu WT, Leiter LA, Yoon K-H, . Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTA TA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial. Lancet. 2013;382(9896):941–950
   PubMed Web of Science ®Google Scholar
• . Lavalle-González FJ, Januszewicz A, Davidson J, . Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial. Diabetologia. 2013;56(12):2582–2592
   PubMed Web of Science ®Google Scholar
• . Schernthaner G, Gross JL, Rosenstock J, . Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52–week, randomized trial. Diabetes Care. 2013;36(9):2508–2515
   PubMed Web of Science ®Google Scholar
• . Stenlöf K, Cefalu WT, Kim KA, . Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise. Diabetes Obes Metab. 2013;15(4):372–382
   PubMed Web of Science ®Google Scholar
• . Wilding JP, Charpentier G, Hollander P, . Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial. Int J Clin Pract. 2013;67(12):1267–1282
   PubMed Web of Science ®Google Scholar
• . Yale JF, Bakris G, Cariou B, . Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease. Diabetes Obes Metab. 2013;15(5):463–473
   PubMed Web of Science ®Google Scholar
• . Forst T, Guthrie R, Goldenberg R, . Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone. Diabetes Obes Metab. 2014;16(5):467–477
   PubMed Web of Science ®Google Scholar
• . Stenlöf K, Cefalu WT, Kim KA, . Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52–week CANTA TA-M study. Curr Med Res Opin. 2014;30(2):163–175
   PubMed Web of Science ®Google Scholar
• . Kolotkin RL, Crosby RD, Kosloski KD, Williams GR. Development of a brief measure to assess quality of life in obesity. Obes Res. 2001;9(2):102–111
   PubMedGoogle Scholar
• . Kolotkin RL, Crosby RD. Psychometric evaluation of the impact of weight on quality of life-lite questionnaire (IWQOL-Lite) in a community sample. Qual Life Res. 2002;11(2):157–171
   PubMed Web of Science ®Google Scholar
• . Blake CE, Hebert JR, Lee DC, . Adults with greater weight satisfaction report more positive health behaviors and have better health status regardless of BMI. J Obes. 2013;2013:291371
   PubMedGoogle Scholar
• . Mostafavi-Darani F, Daniali SS, Azadbakht L. Relationship of body satisfaction, with nutrition and weight control behaviors in women. Int J Prev Med. 2013;4(4):467–474
   PubMedGoogle Scholar
• . Anderson LA, Eyler AA, Galuska DA, Brown DR, Brownson RC. Relationship of satisfaction with body size and trying to lose weight in a national survey of overweight and obese women aged 40 and older, United States. Prev Med. 2002;35(4):390–396
   PubMed Web of Science ®Google Scholar
• . Kolotkin RL, Crosby RD, Williams GR. Assessing weight-related quality of life in obese persons with type 2 diabetes. Diabetes Res Clin Pract. 2003;61(2):125–132
   PubMed Web of Science ®Google Scholar
• . International Society for Pharmacoeconomics and Outcomes Research. ISPOR Quality of Life Regulatory Guidance Issues. Quality of life promotional and label claim issues for drugs, biologicals, and devices. http://www.ispor.org/workpaper/consensus/index.asp. Accessed February 25, 2014
   Google Scholar
• . US Department of Health and Human Services. US Food and Drug Administration. Guidance for Industry. Patient-reported outcome measures: use in medical product development to support labeling claims; 2009. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. Accessed August 27, 2013
   Google Scholar
• . Harris Interactive. Global Weight Management Study: Integrated Findings from the US, UK, and France. Report on file; 2009
   Google Scholar
• . Mapi Values. Qualitative study to assess patient perspective of type II diabetes medication. Report on file; 2007
   Google Scholar
• . Knowledge Networks. Johnson and Johnson study of type 2 diabetics: final report of online survey in US and EU. Report on file; 2008
   Google Scholar
• . RTI Health Solutions. Assessing benefits of weight loss in overweight individuals: with and without type 2 diabetes—In depth interviews. Report on file; 2009
   Google Scholar
• . The Swedish Institute for Health Economics. Willingness-to-pay for weight loss in the US and Europe. Report on file; 2003
   Google Scholar
• . Schnee J. Behavioral Model Advisory Board II meeting summary and recommendations. Report on file; 2010
   Google Scholar
• . Abt Associates Inc. A literature review of patient behavioral attributes affecting treatment adherence in type 2 diabetes. Report on file; 2007
   Google Scholar
• . RTI Health Solutions. Draft components for type 2 diabetes mellitus adherence conceptual model. Report on file; 2008
   Google Scholar
• . Crosby RD, Kolotkin RL, Williams GR. An integrated method to determine meaningful changes in health-related quality of life. J Clin Epidemiol. 2004;57(11):1153–1160
   PubMed Web of Science ®Google Scholar
• . Wexler DJ, Grant RW, Wittenberg E, . Correlates of health-related quality of life in type 2 diabetes. Diabetologia. 2006;49(7):1489–1497
   PubMed Web of Science ®Google Scholar